Novel Wrist MR Imaging System Receives the European CE Mark
By MedImaging International staff writers Posted on 13 Jul 2016 |
Image: The WristView MRI system (Photo courtesy of Aspect Imaging).
A novel hand and wrist imaging system has received CE Mark (Conformité Européenne) approval for the European market, and is now on sale in the European Economic Area (EEA).
The novel hand and wrist Magnetic Resonance Imaging (MRI) imaging system was developed by a life-science startup company, and previously received U.S. Food and Drug Administration (FDA) approval.
The WristView imaging was developed by Aspect Imaging (Tel Aviv, Israel). The company designs and develops compact MR imaging and Nuclear Magnetic Resonance (NMR) systems for preclinical and medical applications.
WristView does not require cooling systems, or a special shielding room, costs less, and requires less training than a full-body MRI scanner. WristView uses a 1-T permanent magnet, and is optimized for hand and wrist applications, in terms of its design and bore size. The system requires very little maintenance, and has an extremely low-level external magnetic field, allowing it to be used anywhere in a hospital or research center. The CE Mark now enables the company to sell the scanner in Australia, New Zealand, Eastern Europe, and some Asian countries.
Founder and CEO of Aspect Imaging, Uri Rapoport, said, “We are thrilled to bring our MR imaging solutions to a wider international audience. Europe makes up a large percentage of the global market for this product in particular, and we’re extremely excited to now have the ability to introduce our system there. We encourage all people suffering from rheumatoid arthritis and carpal tunnel syndrome to demand that their condition be diagnosed with MRI.”
Related Links:
Aspect Imaging
The novel hand and wrist Magnetic Resonance Imaging (MRI) imaging system was developed by a life-science startup company, and previously received U.S. Food and Drug Administration (FDA) approval.
The WristView imaging was developed by Aspect Imaging (Tel Aviv, Israel). The company designs and develops compact MR imaging and Nuclear Magnetic Resonance (NMR) systems for preclinical and medical applications.
WristView does not require cooling systems, or a special shielding room, costs less, and requires less training than a full-body MRI scanner. WristView uses a 1-T permanent magnet, and is optimized for hand and wrist applications, in terms of its design and bore size. The system requires very little maintenance, and has an extremely low-level external magnetic field, allowing it to be used anywhere in a hospital or research center. The CE Mark now enables the company to sell the scanner in Australia, New Zealand, Eastern Europe, and some Asian countries.
Founder and CEO of Aspect Imaging, Uri Rapoport, said, “We are thrilled to bring our MR imaging solutions to a wider international audience. Europe makes up a large percentage of the global market for this product in particular, and we’re extremely excited to now have the ability to introduce our system there. We encourage all people suffering from rheumatoid arthritis and carpal tunnel syndrome to demand that their condition be diagnosed with MRI.”
Related Links:
Aspect Imaging
Latest MRI News
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods
- DW-MRI Lights up Small Ovarian Lesions like Light Bulbs